How much did Arypsa achieve in EBIT for the current year?
In the current year, Arypsa has achieved an EBIT of -4.13 M USD.
Arypsa EBIT 2025
Arypsa EBIT
-4.13 M USD
Ticker
APYI
ISIN
US04538V2034
In 2025, Arypsa's EBIT was -4.13 M USD, a -1.69% increase from the -4.2 M USD EBIT recorded in the previous year.
The Arypsa EBIT history
| YEAR | EBIT (undefined USD) |
|---|---|
| 2008 | -4,126 |
| 2007 | -4,197 |
| 2006 | -3,343 |
| 2005 | -1,684 |
| 2004 | -266 |
| 2003 | 279 |
| 2002 | 130 |
| 2001 | 720 |
| 2000 | -520 |
| 1999 | -640 |
| 1998 | 790 |
| 1997 | -910 |
| 1996 | 450 |
| 1995 | 500 |
| 1994 | 180 |
| 1993 | 170 |
| 1992 | 140 |
| 1991 | 230 |
| 1990 | 200 |
| 1989 | 170 |
Arypsa Revenue, EBIT, Net Income US04538V2034 ·
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Arypsa, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Arypsa from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Arypsa’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Arypsa. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Arypsa’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Arypsa’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Arypsa’s growth potential.
Arypsa Revenue, EBIT and net profit per share
| Date | Arypsa Revenue | Arypsa EBIT | Arypsa Net Income |
|---|---|---|---|
| 2008 | 8.53 M undefined | -4.13 M undefined | -5.19 M undefined |
| 2007 | 10.27 M undefined | -4.2 M undefined | -5.01 M undefined |
| 2006 | 12.69 M undefined | -3.34 M undefined | -3.57 M undefined |
| 2005 | 7.21 M undefined | -1.68 M undefined | -2.5 M undefined |
| 2004 | 2.39 M undefined | -266,000 undefined | -263,000 undefined |
| 2003 | 7.66 M undefined | 279,000 undefined | 162,000 undefined |
| 2002 | 7.38 M undefined | 130,000 undefined | 90,000 undefined |
| 2001 | 7.83 M undefined | 720,000 undefined | 430,000 undefined |
| 2000 | 5.95 M undefined | -520,000 undefined | -510,000 undefined |
| 1999 | 7.22 M undefined | -640,000 undefined | -620,000 undefined |
| 1998 | 8.9 M undefined | 790,000 undefined | 680,000 undefined |
| 1997 | 6.45 M undefined | -910,000 undefined | -650,000 undefined |
| 1996 | 7.12 M undefined | 450,000 undefined | 890,000 undefined |
| 1995 | 6.24 M undefined | 500,000 undefined | 970,000 undefined |
| 1994 | 5.93 M undefined | 180,000 undefined | 10,000 undefined |
| 1993 | 5.63 M undefined | 170,000 undefined | 150,000 undefined |
| 1992 | 6.12 M undefined | 140,000 undefined | 50,000 undefined |
| 1991 | 4.73 M undefined | 230,000 undefined | 200,000 undefined |
| 1990 | 4.62 M undefined | 200,000 undefined | 210,000 undefined |
| 1989 | 4.46 M undefined | 170,000 undefined | 130,000 undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 1989 | 4.46 M USD | 170,000 USD | 130,000 USD |
| 1990 | 4.62 M USD | 200,000 USD | 210,000 USD |
| 1991 | 4.73 M USD | 230,000 USD | 200,000 USD |
| 1992 | 6.12 M USD | 140,000 USD | 50,000 USD |
| 1993 | 5.63 M USD | 170,000 USD | 150,000 USD |
| 1994 | 5.93 M USD | 180,000 USD | 10,000 USD |
| 1995 | 6.24 M USD | 500,000 USD | 970,000 USD |
| 1996 | 7.12 M USD | 450,000 USD | 890,000 USD |
| 1997 | 6.45 M USD | -910,000 USD | -650,000 USD |
| 1998 | 8.9 M USD | 790,000 USD | 680,000 USD |
| 1999 | 7.22 M USD | -640,000 USD | -620,000 USD |
| 2000 | 5.95 M USD | -520,000 USD | -510,000 USD |
| 2001 | 7.83 M USD | 720,000 USD | 430,000 USD |
| 2002 | 7.38 M USD | 130,000 USD | 90,000 USD |
| 2003 | 7.66 M USD | 279,000 USD | 162,000 USD |
| 2004 | 2.39 M USD | -266,000 USD | -263,000 USD |
| 2005 | 7.21 M USD | -1.68 M USD | -2.5 M USD |
| 2006 | 12.69 M USD | -3.34 M USD | -3.57 M USD |
| 2007 | 10.27 M USD | -4.2 M USD | -5.01 M USD |
| 2008 | 8.53 M USD | -4.13 M USD | -5.19 M USD |
Arypsa stock margins US04538V2034 ·
The Arypsa margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Arypsa. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Arypsa.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Arypsa's sales revenue. A higher gross margin percentage indicates that the Arypsa retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Arypsa's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Arypsa's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Arypsa's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Arypsa. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Arypsa's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Arypsa Margin History
| Arypsa Gross margin | Arypsa Profit margin | Arypsa EBIT margin | Arypsa Profit margin |
|---|---|---|---|
| 2008 | 45.94 % | -48.39 % | -60.87 % |
| 2007 | 47.43 % | -40.86 % | -48.72 % |
| 2006 | 46.38 % | -26.34 % | -28.13 % |
| 2005 | 48.71 % | -23.37 % | -34.73 % |
| 2004 | 51.82 % | -11.13 % | -11 % |
| 2003 | 54.19 % | 3.64 % | 2.12 % |
| 2002 | 51.63 % | 1.76 % | 1.22 % |
| 2001 | 54.28 % | 9.2 % | 5.49 % |
| 2000 | 44.37 % | -8.74 % | -8.57 % |
| 1999 | 40.86 % | -8.86 % | -8.59 % |
| 1998 | 48.88 % | 8.88 % | 7.64 % |
| 1997 | 34.88 % | -14.11 % | -10.08 % |
| 1996 | 46.49 % | 6.32 % | 12.5 % |
| 1995 | 49.04 % | 8.01 % | 15.54 % |
| 1994 | 40.98 % | 3.04 % | 0.17 % |
| 1993 | 42.63 % | 3.02 % | 2.66 % |
| 1992 | 47.55 % | 2.29 % | 0.82 % |
| 1991 | 47.99 % | 4.86 % | 4.23 % |
| 1990 | 43.29 % | 4.33 % | 4.55 % |
| 1989 | 44.62 % | 3.81 % | 2.91 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 1989 | 44.62 % | 3.81 % | 2.91 % |
| 1990 | 43.29 % | 4.33 % | 4.55 % |
| 1991 | 47.99 % | 4.86 % | 4.23 % |
| 1992 | 47.55 % | 2.29 % | 0.82 % |
| 1993 | 42.63 % | 3.02 % | 2.66 % |
| 1994 | 40.98 % | 3.04 % | 0.17 % |
| 1995 | 49.04 % | 8.01 % | 15.54 % |
| 1996 | 46.49 % | 6.32 % | 12.5 % |
| 1997 | 34.88 % | -14.11 % | -10.08 % |
| 1998 | 48.88 % | 8.88 % | 7.64 % |
| 1999 | 40.86 % | -8.86 % | -8.59 % |
| 2000 | 44.37 % | -8.74 % | -8.57 % |
| 2001 | 54.28 % | 9.2 % | 5.49 % |
| 2002 | 51.63 % | 1.76 % | 1.22 % |
| 2003 | 54.19 % | 3.64 % | 2.12 % |
| 2004 | 51.82 % | -11.13 % | -11 % |
| 2005 | 48.71 % | -23.37 % | -34.73 % |
| 2006 | 46.38 % | -26.34 % | -28.13 % |
| 2007 | 47.43 % | -40.86 % | -48.72 % |
| 2008 | 45.94 % | -48.39 % | -60.87 % |
Arypsa Aktienanalyse
What does Arypsa do?
Aspyra Inc. is an American company based in California that specializes in the development and distribution of medical IT solutions. The history of Aspyra dates back to 1993 when the company was founded as an independent provider of medical imaging technology. In the following years, Aspyra expanded its business model and focused on developing integrated solutions for the healthcare industry. Today, the company offers a wide range of products and services such as RIS, PACS, LIS, and teleradiology systems that are used by hospitals, clinics, and medical practices worldwide. Aspyra also has specialized divisions within the company that focus on specific solutions. One of these divisions is INSIGHT, which specializes in the development of LIS systems. These solutions provide a specialized software platform that simplifies laboratory management and the workflow of medical tests and results. Another important division of Aspyra is the teleradiology department, which transmits specialized medical imaging findings and reports via telecommunication systems from one radiologist to another. This is particularly advantageous in providing care to patients in rural areas or areas with limited healthcare services. Aspyra also offers various software products, including the PACS system, the Radiology Information System (RIS), and the LIS system. The PACS system allows for the capture of medical images and provides them in electronic form, while the RIS system facilitates the management process of radiology departments and administrative processes related to the data. The LIS system, specifically tailored to the needs of laboratories, also supports the creation of contingency reports and better quality assurance. In recent years, Aspyra has also formed partnerships with other companies in the healthcare industry to expand its product portfolio. This includes a recent collaboration with Healthline Networks and First Databank to combine its IT systems with health data and information from third-party specialists. Aspyra has established itself as a leading provider of medical IT solutions and offers its customers a wide range of products and services. Thanks to its expertise in the healthcare industry, the company has been able to expand its presence in the global market and establish itself as an important partner for medical facilities in North America and Europe. Arypsa ist eines der beliebtesten Unternehmen auf Eulerpool.com.EBIT Details
Analyzing Arypsa's EBIT
Arypsa's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of Arypsa's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
Arypsa's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in Arypsa’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about Arypsa stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Arypsa.
How has the EBIT of Arypsa developed in recent years?
The EBIT of Arypsa has increased by -1.692% decreased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company Arypsa?
The EBIT of Arypsa is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does Arypsa pay?
Over the past 12 months, Arypsa paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Arypsa is expected to pay a dividend of 0 USD.
What is the dividend yield of Arypsa?
The current dividend yield of Arypsa is .
When does Arypsa pay dividends?
Arypsa pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Arypsa?
Arypsa paid dividends every year for the past 0 years.
What is the dividend of Arypsa?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Arypsa located?
Arypsa is assigned to the 'Health' sector.
Wann musste ich die Aktien von Arypsa kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Arypsa from 3/2/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 3/2/2025.
When did Arypsa pay the last dividend?
The last dividend was paid out on 3/2/2025.
What was the dividend of Arypsa in the year 2024?
In the year 2024, Arypsa distributed 0 USD as dividends.
In which currency does Arypsa pay out the dividend?
The dividends of Arypsa are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Arypsa
Our stock analysis for Arypsa Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Arypsa Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
